Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41577-021-00567-2 http://scihub22266oqcxt.onion/10.1038/s41577-021-00567-2 34140665!8211312!34140665     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Rev+Immunol 2021 ; 21 (12): 815-822 Nephropedia Template TP {{tp|p=34140665|t=2021. Using cross-species vaccination approaches to counter emerging infectious diseases |pdf=|usr=}}{{34140665}} gab.com Text Using cross-species vaccination approaches to counter emerging infectious diseases JO: Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34140665 #FOAvip Since the initial use of vaccination in the eighteenth century, our understanding of human and animal immunology has greatly advanced and a wide range of vaccine technologies and delivery systems have been developed. The COVID-19 pandemic response leveraged these innovations to enable rapid development of candidate vaccines within weeks of the viral genetic sequence being made available. The development of vaccines to tackle emerging infectious diseases is a priority for the World Health Organization and other global entities. More than 70% of emerging infectious diseases are acquired from animals, with some causing illness and death in both humans and the respective animal host. Yet the study of critical host-pathogen interactions and the underlying immune mechanisms to inform the development of vaccines for their control is traditionally done in medical and veterinary immunology 'silos'. In this Perspective, we highlight a 'One Health vaccinology' approach and discuss some key areas of synergy in human and veterinary vaccinology that could be exploited to accelerate the development of effective vaccines against these shared health threats. Twit Text FOAVip Using cross-species vaccination approaches to counter emerging infectious diseases ????Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34140665 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34140665 #FOAvip English Wikipedia <ref>{{Cite pmid|34140665}}</ref> Using cross-species vaccination approaches to counter emerging infectious diseases #MMPMID34140665 Warimwe GM; Francis MJ; Bowden TA; Thumbi SM; Charleston B Nat Rev Immunol 2021[Dec]; 21 (12): 815-822 PMID34140665show ga Since the initial use of vaccination in the eighteenth century, our understanding of human and animal immunology has greatly advanced and a wide range of vaccine technologies and delivery systems have been developed. The COVID-19 pandemic response leveraged these innovations to enable rapid development of candidate vaccines within weeks of the viral genetic sequence being made available. The development of vaccines to tackle emerging infectious diseases is a priority for the World Health Organization and other global entities. More than 70% of emerging infectious diseases are acquired from animals, with some causing illness and death in both humans and the respective animal host. Yet the study of critical host-pathogen interactions and the underlying immune mechanisms to inform the development of vaccines for their control is traditionally done in medical and veterinary immunology 'silos'. In this Perspective, we highlight a 'One Health vaccinology' approach and discuss some key areas of synergy in human and veterinary vaccinology that could be exploited to accelerate the development of effective vaccines against these shared health threats. |*Vaccination[MESH] |Animals[MESH] |COVID-19/epidemiology/immunology/prevention & control[MESH] |Communicable Diseases, Emerging/*immunology/*prevention & control[MESH] |Cross Reactions/*immunology[MESH] |Humans[MESH] |SARS-CoV-2/immunology[MESH] |Species Specificity[MESH] |Vaccines/*immunology[MESH]Using cross-species vaccination approaches to counter emerging infecti(epmc).pdf DeepDyve Pubget Overpricing